NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · Real-Time Price · USD
13.64
-1.67 (-10.91%)
At close: Jul 29, 2026, 4:00 PM EDT
13.91
+0.27 (1.98%)
After-hours: Jul 29, 2026, 7:49 PM EDT
NeuroPace Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 14.78 | 21.69 | 13.43 | 18.06 | 6.61 | 19.19 |
Short-Term Investments | 39.2 | 39.37 | 39.33 | 48.4 | 70.8 | 96.4 |
Cash & Short-Term Investments | 53.98 | 61.06 | 52.76 | 66.45 | 77.41 | 115.58 |
Cash Growth | -18.53% | 15.74% | -20.61% | -14.15% | -33.03% | 203.54% |
Accounts Receivable | 14.79 | 14.68 | 12.85 | 12.31 | 7.48 | 7.09 |
Inventory | 16.69 | 16.9 | 13.38 | 11.21 | 9.71 | 7.82 |
Other Current Assets | 1.52 | 1.44 | 2.35 | 2.74 | 3.11 | 2.32 |
Total Current Assets | 86.98 | 94.07 | 81.34 | 92.72 | 97.71 | 132.82 |
Net Property, Plant & Equipment | 10.96 | 11.26 | 12.9 | 14.41 | 15.9 | 0.6 |
Other Long-Term Assets | 0.96 | 0.24 | 0.41 | 0.52 | 0.49 | 0.14 |
Total Assets | 98.9 | 105.57 | 94.65 | 107.65 | 114.11 | 133.56 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 4.51 | 2.22 | 2.95 | 2.33 | 2.15 | 1.38 |
Accrued Expenses | 9.34 | 13.34 | 9.79 | 11.18 | 7.41 | 7.92 |
Current Portion of Leases | 2.19 | 2.12 | 1.86 | 1.63 | 1.42 | - |
Unearned Revenue | 0.13 | 0.14 | 0.56 | 1.09 | - | - |
Total Current Liabilities | 16.17 | 17.81 | 15.16 | 16.23 | 10.98 | 9.3 |
Long-Term Debt | 59.02 | 58.88 | 59.53 | 56.95 | 52.91 | 49.85 |
Long-Term Leases | 9.26 | 9.84 | 11.95 | 13.81 | 15.44 | - |
Other Long-Term Liabilities | - | - | - | - | - | 0.91 |
Total Long-Term Liabilities | 68.28 | 68.72 | 71.48 | 70.77 | 68.35 | 50.76 |
Total Liabilities | 84.44 | 86.53 | 86.63 | 87 | 79.33 | 60.06 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 |
Additional Paid-in Capital | 573.52 | 571.41 | 538.93 | 524.44 | 506.71 | 497.52 |
Accumulated Other Comprehensive Income | - | - | - | - | -1.11 | -0.27 |
Retained Earnings | -559.1 | -552.42 | -530.95 | -503.81 | -470.85 | -423.77 |
Total Common Shareholders' Equity | 14.45 | 19.03 | 8.01 | 20.65 | 34.78 | 73.5 |
Shareholders' Equity | 14.45 | 19.03 | 8.01 | 20.65 | 34.78 | 73.5 |
Total Liabilities & Equity | 98.9 | 105.57 | 94.65 | 107.65 | 114.11 | 133.56 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 70.46 | 70.84 | 73.34 | 72.4 | 69.77 | 49.85 |
Net Cash (Debt) | -16.48 | -9.78 | -20.58 | -5.94 | 7.64 | 65.74 |
Net Cash Growth | - | - | - | - | -88.38% | - |
Net Cash Per Share | -0.49 | -0.30 | -0.71 | -0.23 | 0.31 | 3.96 |
Book Value | 14.45 | 19.03 | 8.01 | 20.65 | 34.78 | 73.5 |
Book Value Per Share | 0.43 | 0.58 | 0.28 | 0.80 | 1.41 | 4.43 |
Tangible Book Value | 14.45 | 19.03 | 8.01 | 20.65 | 34.78 | 73.5 |
Tangible Book Value Per Share | 0.43 | 0.58 | 0.28 | 0.80 | 1.41 | 4.43 |